Regulus Therapeutics
RGLS
#9133
Rank
$90.39 M
Marketcap
$1.38
Share price
-6.76%
Change (1 day)
-41.53%
Change (1 year)

Operating Margin for Regulus Therapeutics (RGLS)

Operating Margin as of March 2025 (TTM): -118.00%

According to Regulus Therapeutics's latest financial reports and stock price the company's current Operating Margin is -118.00%. At the end of 2020 the company had an Operating Margin of -157.21%.

Operating Margin history for Regulus Therapeutics from 2012 to 2020

Operating Margin at the end of each year

Year Operating Margin Change
2020-157.21%-42.23%
2019-272.12%-99.6%
2018-67,565.28%-32.53%
2017-100,141.67%1361.01%
2016-6,854.27%2451.52%
2015-268.64%-63.65%
2014-739.07%673.78%
2013-95.51%-30.36%
2012-137.15%155.7%
2011-53.64%-70.41%
2010-181.25%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
13.12%-111.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
15.12%-112.81%๐Ÿ‡ซ๐Ÿ‡ท France
19.69%-116.69%๐Ÿ‡บ๐Ÿ‡ธ USA
16.07%-113.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
-16.78%-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-149.18% 26.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-17.34%-85.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-48.30%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.